Raymond James Financial’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$769K Sell
29,876
-322
-1% -$7.46K ﹤0.01% 4185
2026
Q1
$621K Buy
30,198
+17,698
+142% +$399K ﹤0.01% 4205
2025
Q4
$296K Buy
+12,500
New +$304K ﹤0.01% 4582
2025
Q3
– Sell
-4,895
Closed -$113K – 6299
2025
Q2
$113K Buy
+4,895
New +$113K ﹤0.01% 4817

Other funds holding PRVA

Raymond James Financial's PRVA Position: Q2 2026 in Review

Raymond James Financial reduced its Privia Health (PRVA) stake by 1.1% in Q2 2026, selling an estimated $7.46K and leaving 29,876 shares worth $769K. The position accounts for ﹤0.01% of the portfolio, ranked #4185.

Raymond James Financial first reported a position in PRVA in Q2 2025 and has held it in 4 quarters since. 302 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Raymond James Financial held 29,876 shares of Privia Health worth $769K as of Q2 2026.
  • Raymond James Financial sold 322 Privia Health shares in Q2 2026, an estimated $7.46K.
  • Privia Health made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #4185 holding.
  • Raymond James Financial first reported a position in Privia Health in Q2 2025 and has held it in 4 quarters since.
  • 302 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.